个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT).

| 认领 | 导出 | |

文献详情

资源类型：
作者：
Chan, Anthony T. C.[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Hui, Edwin Pun[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Ngan, Roger K. C.[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Tung, Stewart Yuk[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Cheng, Ashley Chi Kin[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Ng, Wai Tong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Lee, Victor H. F.[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Ma, Brigette[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Cheng, Hoi Ching[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Wong, Frank C. S.[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Loong, Herbert H. F.[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Tong, Macy[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Poon, Daren M. C.[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Ahuja, Anil Tejbhan[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; King, Ann Dorothy[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Wang, Ki[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Mo, Frankie[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Zee, Benny C. Y.[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Chan, Allen K. C.[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Lo, Y. M. Dennis[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ;
机构： [1]Chinese Univ Hong Kong, Dept Clin Oncol, State Key Lab Oncol South China, Hong Kong, Peoples R China; [2]Chinese Univ Hong Kong, Hong Kong Canc Inst, Dept Clin Oncol,Sir YK Pao Ctr Canc, Partner State Key Lab Oncol South China,Shatin, Hong Kong, Peoples R China; [3]Chinese Univ Hong Kong, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [4]Queen Elizabeth Hosp, Dept Clin Oncol, Hong Kong, Peoples R China; [5]Tuen Mun Hosp, Hong Kong, Peoples R China; [6]Princess Margaret Hosp, Dept Oncol, Kowloon, Hong Kong, Peoples R China; [7]Pamela Youde Nethersole Eastern Hosp, Dept Clin Oncol, Chai Wan, Hong Kong, Peoples R China; [8]Univ Hong Kong, Queen Mary Hosp, Dept Clin Oncol, Hong Kong, Peoples R China; [9]Chinese Univ Hong Kong, Hong Kong Canc Inst, Dept Clin Oncol,Sir YK Pao Ctr Canc, State Key Lab Oncol South China,Shatin, Hong Kong, Peoples R China; [10]Tuen Mun Hosp, Dept Clin Oncol, Tuen Mun, Hong Kong, Peoples R China; [11]Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; [12]Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China; [13]Prince Wales Hosp, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China; [14]Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Hong Kong, Peoples R China; [15]Chinese Univ Hong Kong, Dept Clin Oncol, Sir YK Pao Ctr Canc, State Key Lab Oncol South China,Shatin, Hong Kong, Peoples R China; [16]Chinese Univ Hong Kong, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; [17]Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China
出处：
DOI： 10.1200/JCO.2017.35.15_suppl.6002
ISSN：
语种：
外文
被引次数：
WOS：
中科院(CAS)分区：
出版当年[2017]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
最新[2023]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
第一作者：
第一作者机构： [1]Chinese Univ Hong Kong, Dept Clin Oncol, State Key Lab Oncol South China, Hong Kong, Peoples R China; [2]Chinese Univ Hong Kong, Hong Kong Canc Inst, Dept Clin Oncol,Sir YK Pao Ctr Canc, Partner State Key Lab Oncol South China,Shatin, Hong Kong, Peoples R China; [3]Chinese Univ Hong Kong, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [4]Queen Elizabeth Hosp, Dept Clin Oncol, Hong Kong, Peoples R China; [5]Tuen Mun Hosp, Hong Kong, Peoples R China; [6]Princess Margaret Hosp, Dept Oncol, Kowloon, Hong Kong, Peoples R China; [7]Pamela Youde Nethersole Eastern Hosp, Dept Clin Oncol, Chai Wan, Hong Kong, Peoples R China; [8]Univ Hong Kong, Queen Mary Hosp, Dept Clin Oncol, Hong Kong, Peoples R China; [9]Chinese Univ Hong Kong, Hong Kong Canc Inst, Dept Clin Oncol,Sir YK Pao Ctr Canc, State Key Lab Oncol South China,Shatin, Hong Kong, Peoples R China; [10]Tuen Mun Hosp, Dept Clin Oncol, Tuen Mun, Hong Kong, Peoples R China; [11]Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; [12]Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China; [13]Prince Wales Hosp, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China; [14]Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Hong Kong, Peoples R China; [15]Chinese Univ Hong Kong, Dept Clin Oncol, Sir YK Pao Ctr Canc, State Key Lab Oncol South China,Shatin, Hong Kong, Peoples R China; [16]Chinese Univ Hong Kong, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; [17]Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China
推荐引用方式(GB/T 7714)：
Chan Anthony T. C.,Hui Edwin Pun,Ngan Roger K. C.,et al.A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT).[J].JOURNAL OF CLINICAL ONCOLOGY.2017,35:-.doi:10.1200/JCO.2017.35.15_suppl.6002.
APA：
Chan, Anthony T. C.,Hui, Edwin Pun,Ngan, Roger K. C.,Tung, Stewart Yuk,Cheng, Ashley Chi Kin...&Lo, Y. M. Dennis.(2017).A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT)..JOURNAL OF CLINICAL ONCOLOGY,35,
MLA：
Chan, Anthony T. C.,et al."A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT).".JOURNAL OF CLINICAL ONCOLOGY 35.(2017):-

资源点击量：43370 今日访问量：0 总访问量：3120 更新日期：2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号